Latest Developments in Global Arthrogryposis Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Arthrogryposis Market

  • Pharmaceutical
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In February 2022, Smith + Nephew introduced the CORI Surgical System in Japan, a streamlined and portable robotic platform tailored for space-constrained operating rooms. This innovative system enhances patient flow and optimizes surgical processes within medical facilities. By addressing the challenges of crowded surgical environments, the CORI Surgical System aims to improve overall operational efficiency in surgical units
  • In April 2021, Orthofix entered into an exclusive licensing agreement with IGEA to market its range of soft tissue and cartilage stimulation products in the United States and Canada. This collaboration aims to leverage both companies' strengths to enhance the availability of innovative treatment options for patients. By focusing on this specialized product portfolio, Orthofix seeks to expand its footprint in the orthopedic market across North America

Frequently Asked Questions

The market is segmented based on Segmentation, By Type (Distal Arthrogryposis Type 4 (scoliosis), Distal Arthrogryposis Type 2a, Distal Arthrogryposis Type 2b, Distal ArthrogryposisTtype 3, Distal Arthrogryposis Type 4, Distal Arthrogryposis Type 5, Distal Arthrogryposis Type 6, Distal Arthrogryposis Type 7, Distal Arthrogryposis Type 8, Distal Arthrogryposis Type 9, and Distal Arthrogryposis Type 10), Treatment Type (Occupational Therapists, Physical Therapy, Surgery, Imaging Diagnostics, and CT scan), Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies and others) – Industry Trends and Forecast to 2031 .
The Global Arthrogryposis Market size was valued at USD 254.20 USD Million in 2023.
The Global Arthrogryposis Market is projected to grow at a CAGR of 3.7% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.